US$11.4 Billion Deal: Innovent Biologics (Xìn Dá Shēng Wù 信达生物, 01801.HK) and Takeda (Wǔ Tián Zhì Yào 武田制药) Announce Global BD Collaboration to Co‑develop Three Oncology CandidatesChina Finance China StartupsHealthcare, Innovent Biologics, Oncology, Pharmaceuticals, Takeda October 22, 2025
RMB Stock Counter in Stock Connect: Why It’s Triggering a Trillion-RMB Rally in A-Shares & H-SharesChina Finance Tech in ChinaA-Shares, Alibaba, Guotai Junan International, Hong Kong, Innovent Biologics, Kuaishou, Meituan, SMIC, Stock Connect, Tencent July 8, 2025
Innovent Biologics (Xìndá Shēngwù 信达生物) Stock Jumps 18% on Promising IBI363 Lung Cancer Data, Igniting the Innovative Drug SectorChina Finance3SBio, Biotech, CSPC Pharmaceutical Group, Innovation, Innovent Biologics, Pharmaceuticals June 4, 2025
